Home > Share Market > Stocks > Lincoln pharmaceuticals > Financial Statements > LINCOLN Key Financial Ratios

Lincoln pharmaceuticals Financial Statements

Lincoln pharmaceuticals Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 9.75 7.18 0.10 (10)
Op profit growth 33 25.30 11.80 15.40
EBIT growth 23.20 34.10 17.40 2.25
Net profit growth 21 48.60 23.10 18.80
Profitability ratios (%)        
OPM 20.60 17 14.50 13
EBIT margin 20.10 17.90 14.30 12.20
Net profit margin 14.70 13.30 9.60 7.81
RoCE 24.20 22.40 18.30 17.80
RoNW 4.52 4.79 4.16 4.22
RoA 4.41 4.15 3.07 2.85
Per share ratios ()        
EPS 31.10 25.70 17.30 14.10
Dividend per share 1.50 1.50 1.50 1.20
Cash EPS 27.30 22.10 14.30 11.30
Book value per share 188 157 112 96.20
Valuation ratios        
P/E 7.22 5.20 12.10 16.80
P/CEPS 8.22 6.07 14.80 20.90
P/B 1.20 0.85 1.88 2.45
EV/EBIDTA 4.70 3.37 8.09 10.60
Payout (%)        
Dividend payout -- 7.04 8.66 8.53
Tax payout (26) (23) (25) (25)
Liquidity ratios        
Debtor days 91.50 99.50 101 86.70
Inventory days 40.40 43.80 41.90 32.80
Creditor days (62) (58) (50) (39)
Leverage ratios        
Interest coverage (55) (34) (9.50) (6.60)
Net debt / equity -- -- 0.21 0.27
Net debt / op. profit (0.20) (0.10) 0.89 1.13
Cost breakup ()        
Material costs (47) (47) (53) (60)
Employee costs (14) (15) (14) (10)
Other costs (19) (21) (18) (16)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000